"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SKIN.
| Descriptor ID |
D012878
|
| MeSH Number(s) |
C04.588.805 C17.800.882
|
| Concept/Terms |
Skin Neoplasms- Skin Neoplasms
- Neoplasms, Skin
- Neoplasm, Skin
- Skin Neoplasm
Cancer of Skin- Cancer of Skin
- Skin Cancers
- Cancer of the Skin
- Skin Cancer
- Cancer, Skin
- Cancers, Skin
|
Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".
This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 8 | 2 | 10 |
| 1997 | 5 | 1 | 6 |
| 1998 | 4 | 1 | 5 |
| 1999 | 12 | 0 | 12 |
| 2000 | 7 | 2 | 9 |
| 2001 | 11 | 1 | 12 |
| 2002 | 10 | 3 | 13 |
| 2003 | 8 | 0 | 8 |
| 2004 | 10 | 2 | 12 |
| 2005 | 8 | 2 | 10 |
| 2006 | 15 | 3 | 18 |
| 2007 | 12 | 1 | 13 |
| 2008 | 13 | 0 | 13 |
| 2009 | 9 | 2 | 11 |
| 2010 | 11 | 3 | 14 |
| 2011 | 16 | 2 | 18 |
| 2012 | 22 | 2 | 24 |
| 2013 | 14 | 2 | 16 |
| 2014 | 16 | 6 | 22 |
| 2015 | 20 | 4 | 24 |
| 2016 | 15 | 3 | 18 |
| 2017 | 17 | 3 | 20 |
| 2018 | 12 | 2 | 14 |
| 2019 | 21 | 3 | 24 |
| 2020 | 16 | 2 | 18 |
| 2021 | 22 | 1 | 23 |
| 2022 | 9 | 0 | 9 |
| 2023 | 17 | 1 | 18 |
| 2024 | 19 | 6 | 25 |
| 2025 | 13 | 2 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
AI-assisted Diagnosis of Nonmelanoma Skin Cancer in Resource-Limited Settings. Cancer Epidemiol Biomarkers Prev. 2025 Jul 01; 34(7):1080-1088.
-
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer. N Engl J Med. 2025 Jun 19; 392(23):2346-2356.
-
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma. J Clin Oncol. 2025 Jul 20; 43(21):2398-2408.
-
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104. J Neurooncol. 2025 Jul; 173(3):751-757.
-
Artificial Intelligence in Dermatology: A Comprehensive Review of Approved Applications, Clinical Implementation, and Future Directions. Int J Dermatol. 2025 Sep; 64(9):1568-1583.
-
Review of Non-Invasive Imaging Technologies for Cutaneous Melanoma. Biosensors (Basel). 2025 May 07; 15(5).
-
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma. Pigment Cell Melanoma Res. 2025 May; 38(3):e70027.
-
Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5. J Cutan Pathol. 2026 Jan; 53(1):91-100.
-
External validation of a model to predict recurrence-free and melanoma-specific survival for patients with melanoma after sentinel node biopsy. Br J Surg. 2025 03 28; 112(4).
-
Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with Melanoma. Ann Surg Oncol. 2025 May; 32(5):3203-3211.